BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31151573)

  • 1. Preparing data for multiparametric PET/MR imaging: Influence of PET point spread function modelling and EPI distortion correction on the spatial correlation of [
    Olin A; Krogager L; Rasmussen JH; Andersen FL; Specht L; Beyer T; Kjaer A; Fischer BM; Hansen AE
    Phys Med; 2019 May; 61():1-7. PubMed ID: 31151573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted Imaging Voxelwise-matched Analyses of Lung Cancer at 3.0-T PET/MRI: Reverse Phase Encoding Approach for Echo-planar Imaging Distortion Correction.
    Besson FL; Fernandez B; Faure S; Mercier O; Seferian A; Blanchet É; Mignard X; Chetouani A; Bulifon S; Mussot S; Parent F; Bouderraoui F; Montani D; Mitilian D; Fadel E; Ghigna-Bellinzoni MR; Cherkaoui H; Comtat C; Lebon V; Durand E
    Radiology; 2020 Jun; 295(3):692-700. PubMed ID: 32208099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma.
    Rasmussen JH; Nørgaard M; Hansen AE; Vogelius IR; Aznar MC; Johannesen HH; Costa J; Engberg AM; Kjær A; Specht L; Fischer BM
    J Nucl Med; 2017 Jan; 58(1):69-74. PubMed ID: 27609790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Point-Spread Function Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging.
    Aklan B; Oehmigen M; Beiderwellen K; Ruhlmann M; Paulus DH; Jakoby BW; Ritt P; Quick HH
    J Nucl Med; 2016 Jan; 57(1):78-84. PubMed ID: 26471697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.
    Trada Y; Keall P; Jameson M; Moses D; Lin P; Chlap P; Holloway L; Min M; Forstner D; Fowler A; Lee MT
    Eur Radiol; 2023 Dec; 33(12):8788-8799. PubMed ID: 37405500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.
    Covello M; Cavaliere C; Aiello M; Cianelli MS; Mesolella M; Iorio B; Rossi A; Nicolai E
    Eur J Radiol; 2015 Jul; 84(7):1269-76. PubMed ID: 25958189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of positron emission tomography diffusion-weighted imaging (PET/DWI) registration quality in a PET/MR scanner: Zoomed DWI vs. Conventional DWI.
    Sagiyama K; Watanabe Y; Kamei R; Baba S; Honda H
    J Magn Reson Imaging; 2016 Apr; 43(4):853-8. PubMed ID: 26440585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized
    Hundshammer C; Braeuer M; Müller CA; Hansen AE; Schillmaier M; Düwel S; Feuerecker B; Glaser SJ; Haase A; Weichert W; Steiger K; Cabello J; Schilling F; Hövener JB; Kjær A; Nekolla SG; Schwaiger M
    Theranostics; 2018; 8(17):4765-4780. PubMed ID: 30279736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.
    Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Kassai Y; Yui M; Matsumoto S; Sugimura K
    Eur J Radiol; 2015 Nov; 84(11):2321-31. PubMed ID: 26231045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
    Baba S; Isoda T; Maruoka Y; Kitamura Y; Sasaki M; Yoshida T; Honda H
    J Nucl Med; 2014 May; 55(5):736-42. PubMed ID: 24665089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
    Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
    Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: comparison with an MR-based method in FDG imaging.
    Ibaraki M; Matsubara K; Shinohara Y; Shidahara M; Sato K; Yamamoto H; Kinoshita T
    Ann Nucl Med; 2022 Aug; 36(8):717-727. PubMed ID: 35616808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
    Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.